###begin article-title 0
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
Genetic association analysis of LARS2 with type 2 diabetes
###end article-title 0
###begin title 1
Aims/hypothesis
###end title 1
###begin p 2
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
LARS2 has been previously identified as a potential type 2 diabetes susceptibility gene through the low-frequency H324Q (rs71645922) variant (minor allele frequency [MAF] 3.0%). However, this association did not achieve genome-wide levels of significance. The aim of this study was to establish the true contribution of this variant and common variants in LARS2 (MAF > 5%) to type 2 diabetes risk.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 279 291 <span type="species:ncbi:9606">participants</span>
###xml 605 617 <span type="species:ncbi:9606">participants</span>
We combined genome-wide association data (n = 10,128) from the DIAGRAM consortium with independent data derived from a tagging single nucleotide polymorphism (SNP) approach in Dutch individuals (n = 999) and took forward two SNPs of interest to replication in up to 11,163 Dutch participants (rs17637703 and rs952621). In addition, because inspection of genome-wide association study data identified a cluster of low-frequency variants with evidence of type 2 diabetes association, we attempted replication of rs9825041 (a proxy for this group) and the previously identified H324Q variant in up to 35,715 participants of European descent.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
No association between the common SNPs in LARS2 and type 2 diabetes was found. Our replication studies for the two low-frequency variants, rs9825041 and H324Q, failed to confirm an association with type 2 diabetes in Dutch, Scandinavian and UK samples (OR 1.03 [95% CI 0.95-1.12], p = 0.45, n = 31,962 and OR 0.99 [0.90-1.08], p = 0.78, n = 35,715 respectively).
###end p 6
###begin title 7
Conclusions/interpretation
###end title 7
###begin p 8
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
In this study, the largest study examining the role of sequence variants in LARS2 in type 2 diabetes susceptibility, we found no evidence to support previous data indicating a role in type 2 diabetes susceptibility.
###end p 8
###begin title 9
Electronic supplementary material
###end title 9
###begin p 10
The online version of this article (doi:10.1007/s00125-009-1557-7) contains supplementary material, which is available to authorised users.
###end p 10
###begin title 11
Keywords
###end title 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 579 585 579 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MT-TL1</italic>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 1112 1117 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 1341 1342 1341 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1352 1353 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1364 1365 1364 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
Changes in mitochondrial function are observed in patients with type 2 diabetes and their first-degree relatives. Previous studies have indicated that genes involved in oxidative phosphorylation are downregulated in the muscle cells of type 2 diabetes patients [1]. Furthermore, the muscle mitochondria from patients with type 2 diabetes have an impaired bioenergetic capacity [2]. Mitochondria also play an important role in insulin secretion and sensitivity [3, 4]. Previously, our group has shown that a mutation in the mitochondrial DNA-encoded tRNA-Leu(UUR), encoded by the MT-TL1 gene is associated with maternally inherited diabetes and deafness [5]. In addition, an H324Q (rs71645922) variant in the nuclear encoded mitochondrial LARS2 gene has shown an association with type 2 diabetes in work previously carried out by our group [6]. The LARS2 gene encodes for the mitochondrial leucyl tRNA synthetase (EC 6.1.1.4), which catalyses the aminoacylation of both mitochondrial leucyl tRNAs with leucine and is therefore essential for mitochondrial protein synthesis. By analysing the coding region for the LARS2 gene, we found the H324Q (rs71645922) variant and demonstrated an association with type 2 diabetes susceptibility in a meta-analysis of four independent cohorts from the Netherlands and Denmark (OR 1.40 [95% CI 1.12-1.76], p = 0.004, n = 7,836) [6].
###end p 13
###begin p 14
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 221 223 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
In recent years the advent of genome-wide association studies (GWAS) and the accumulation of large data sets capable of detecting associations to levels of genome-wide significance appropriate for such studies (p < 5 x 10-8) have identified close to 20 loci impacting on type 2 diabetes susceptibility. However, low-frequency variants such as H324Q are generally poorly captured by such studies. We set out therefore to re-evaluate the possible contribution of this low-frequency variant to type 2 diabetes susceptibility in appropriately sized samples. We also used a combination of publicly available (DIAGRAM consortium: , accessed 2 May 2008) and newly derived tagging single nucleotide polymorphism (SNP) data to undertake the most comprehensive assessment of the LARS2 locus yet performed.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Study samples</bold>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 914 915 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1190 1191 1190 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1483 1484 1483 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1559 1561 1559 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1563 1565 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1816 1817 1816 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 2026 2028 2026 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 2239 2244 2239 2244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 2529 2531 2529 2531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 2846 2847 2846 2847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 3171 3173 3171 3173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 3175 3177 3175 3177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 3549 3550 3549 3550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3629 3630 3629 3630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3800 3802 3800 3802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 3804 3806 3804 3806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 4309 4311 4309 4311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 4313 4315 4313 4315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 4360 4361 4360 4361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 4363 4370 4363 4370 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 4370 4398 4370 4398 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="17">Description of study samples</p>
###xml 4370 4398 4370 4398 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="17">Description of study samples</p></caption>
###xml 4398 4403 4398 4403 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Study</th>
###xml 4417 4418 4417 4418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 4403 4427 4403 4427 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Participants, <italic>n</italic> (% male)</th>
###xml 4427 4447 4427 4447 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Mean age, years (SD)</th>
###xml 4462 4463 4462 4463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 4447 4468 4447 4468 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Mean BMI , kg/m<sup>2</sup> (SD)</th>
###xml 4398 4468 4398 4468 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Study</th><th colspan="2">Participants, <italic>n</italic> (% male)</th><th colspan="2">Mean age, years (SD)</th><th colspan="2">Mean BMI , kg/m<sup>2</sup> (SD)</th></tr>
###xml 4468 4476 4468 4476 <th xmlns:xlink="http://www.w3.org/1999/xlink">Controls</th>
###xml 4476 4481 4476 4481 <th xmlns:xlink="http://www.w3.org/1999/xlink">Cases</th>
###xml 4481 4489 4481 4489 <th xmlns:xlink="http://www.w3.org/1999/xlink">Controls</th>
###xml 4489 4494 4489 4494 <th xmlns:xlink="http://www.w3.org/1999/xlink">Cases</th>
###xml 4494 4502 4494 4502 <th xmlns:xlink="http://www.w3.org/1999/xlink">Controls</th>
###xml 4502 4507 4502 4507 <th xmlns:xlink="http://www.w3.org/1999/xlink">Cases</th>
###xml 4468 4507 4468 4507 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th></tr>
###xml 4398 4507 4398 4507 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Study</th><th colspan="2">Participants, <italic>n</italic> (% male)</th><th colspan="2">Mean age, years (SD)</th><th colspan="2">Mean BMI , kg/m<sup>2</sup> (SD)</th></tr><tr><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th></tr></thead>
###xml 4507 4510 4507 4510 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL1</td>
###xml 4510 4518 4510 4518 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">519 (55)</td>
###xml 4518 4526 4518 4526 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">480 (52)</td>
###xml 4526 4532 4526 4532 <td xmlns:xlink="http://www.w3.org/1999/xlink">65 (8)</td>
###xml 4532 4538 4532 4538 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">67 (8)</td>
###xml 4538 4548 4538 4548 <td xmlns:xlink="http://www.w3.org/1999/xlink">26.4 (4.5)</td>
###xml 4548 4558 4548 4558 <td xmlns:xlink="http://www.w3.org/1999/xlink">28.8 (4.6)</td>
###xml 4507 4558 4507 4558 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL1</td><td char="(" align="char">519 (55)</td><td char="(" align="char">480 (52)</td><td>65 (8)</td><td char="(" align="char">67 (8)</td><td>26.4 (4.5)</td><td>28.8 (4.6)</td></tr>
###xml 4558 4561 4558 4561 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL2</td>
###xml 4561 4571 4561 4571 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1,517 (44)</td>
###xml 4571 4579 4571 4579 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">821 (50)</td>
###xml 4579 4585 4579 4585 <td xmlns:xlink="http://www.w3.org/1999/xlink">53 (7)</td>
###xml 4585 4592 4585 4592 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">61 (11)</td>
###xml 4592 4602 4592 4602 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.5 (3.6)</td>
###xml 4602 4612 4602 4612 <td xmlns:xlink="http://www.w3.org/1999/xlink">29.0 (4.6)</td>
###xml 4558 4612 4558 4612 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL2</td><td char="(" align="char">1,517 (44)</td><td char="(" align="char">821 (50)</td><td>53 (7)</td><td char="(" align="char">61 (11)</td><td>25.5 (3.6)</td><td>29.0 (4.6)</td></tr>
###xml 4612 4615 4612 4615 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL3</td>
###xml 4615 4623 4615 4623 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">920 (61)</td>
###xml 4623 4631 4623 4631 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">501 (46)</td>
###xml 4631 4638 4631 4638 <td xmlns:xlink="http://www.w3.org/1999/xlink">48 (13)</td>
###xml 4638 4645 4638 4645 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">71 (10)</td>
###xml 4645 4649 4645 4649 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.a.</td>
###xml 4649 4659 4649 4659 <td xmlns:xlink="http://www.w3.org/1999/xlink">27.8 (4.1)</td>
###xml 4612 4659 4612 4659 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL3</td><td char="(" align="char">920 (61)</td><td char="(" align="char">501 (46)</td><td>48 (13)</td><td char="(" align="char">71 (10)</td><td>n.a.</td><td>27.8 (4.1)</td></tr>
###xml 4659 4662 4659 4662 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL4</td>
###xml 4662 4672 4662 4672 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5,183 (41)</td>
###xml 4672 4682 4672 4682 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1,222 (39)</td>
###xml 4682 4688 4682 4688 <td xmlns:xlink="http://www.w3.org/1999/xlink">69 (9)</td>
###xml 4688 4694 4688 4694 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">73 (9)</td>
###xml 4694 4704 4694 4704 <td xmlns:xlink="http://www.w3.org/1999/xlink">26.0 (3.9)</td>
###xml 4704 4714 4704 4714 <td xmlns:xlink="http://www.w3.org/1999/xlink">27.4 (4.0)</td>
###xml 4659 4714 4659 4714 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL4</td><td char="(" align="char">5,183 (41)</td><td char="(" align="char">1,222 (39)</td><td>69 (9)</td><td char="(" align="char">73 (9)</td><td>26.0 (3.9)</td><td>27.4 (4.0)</td></tr>
###xml 4714 4717 4714 4717 <td xmlns:xlink="http://www.w3.org/1999/xlink">DK1</td>
###xml 4717 4725 4717 4725 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">514 (46)</td>
###xml 4725 4733 4725 4733 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">706 (48)</td>
###xml 4733 4740 4733 4740 <td xmlns:xlink="http://www.w3.org/1999/xlink">57 (10)</td>
###xml 4740 4747 4740 4747 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">59 (10)</td>
###xml 4747 4757 4747 4757 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.9 (3.8)</td>
###xml 4757 4767 4757 4767 <td xmlns:xlink="http://www.w3.org/1999/xlink">29.3 (5.1)</td>
###xml 4714 4767 4714 4767 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DK1</td><td char="(" align="char">514 (46)</td><td char="(" align="char">706 (48)</td><td>57 (10)</td><td char="(" align="char">59 (10)</td><td>25.9 (3.8)</td><td>29.3 (5.1)</td></tr>
###xml 4767 4770 4767 4770 <td xmlns:xlink="http://www.w3.org/1999/xlink">UK1</td>
###xml 4770 4780 4770 4780 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5,126 (51)</td>
###xml 4780 4790 4780 4790 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4,124 (55)</td>
###xml 4790 4797 4790 4797 <td xmlns:xlink="http://www.w3.org/1999/xlink">60 (13)</td>
###xml 4797 4803 4797 4803 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">66 (6)</td>
###xml 4803 4814 4803 4814 <td xmlns:xlink="http://www.w3.org/1999/xlink">26.9 (11.4)</td>
###xml 4814 4825 4814 4825 <td xmlns:xlink="http://www.w3.org/1999/xlink">31.2 (13.8)</td>
###xml 4767 4825 4767 4825 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UK1</td><td char="(" align="char">5,126 (51)</td><td char="(" align="char">4,124 (55)</td><td>60 (13)</td><td char="(" align="char">66 (6)</td><td>26.9 (11.4)</td><td>31.2 (13.8)</td></tr>
###xml 4825 4828 4825 4828 <td xmlns:xlink="http://www.w3.org/1999/xlink">UK2</td>
###xml 4828 4839 4828 4839 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10,220 (50)</td>
###xml 4839 4849 4839 4849 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1,853 (61)</td>
###xml 4849 4855 4849 4855 <td xmlns:xlink="http://www.w3.org/1999/xlink">42 (7)</td>
###xml 4855 4861 4855 4861 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">57 (9)</td>
###xml 4871 4872 4871 4872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 4861 4872 4861 4872 <td xmlns:xlink="http://www.w3.org/1999/xlink">27.2 (6.4)<sup>a</sup></td>
###xml 4872 4882 4872 4882 <td xmlns:xlink="http://www.w3.org/1999/xlink">31.8 (6.7)</td>
###xml 4825 4882 4825 4882 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UK2</td><td char="(" align="char">10,220 (50)</td><td char="(" align="char">1,853 (61)</td><td>42 (7)</td><td char="(" align="char">57 (9)</td><td>27.2 (6.4)<sup>a</sup></td><td>31.8 (6.7)</td></tr>
###xml 4882 4885 4882 4885 <td xmlns:xlink="http://www.w3.org/1999/xlink">FL1</td>
###xml 4885 4893 4885 4893 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">353 (53)</td>
###xml 4893 4901 4893 4901 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">402 (55)</td>
###xml 4901 4908 4901 4908 <td xmlns:xlink="http://www.w3.org/1999/xlink">60 (10)</td>
###xml 4908 4915 4908 4915 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">61 (10)</td>
###xml 4915 4925 4915 4925 <td xmlns:xlink="http://www.w3.org/1999/xlink">26.1 (3.6)</td>
###xml 4925 4935 4925 4935 <td xmlns:xlink="http://www.w3.org/1999/xlink">28.7 (4.5)</td>
###xml 4882 4935 4882 4935 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>FL1</td><td char="(" align="char">353 (53)</td><td char="(" align="char">402 (55)</td><td>60 (10)</td><td char="(" align="char">61 (10)</td><td>26.1 (3.6)</td><td>28.7 (4.5)</td></tr>
###xml 4935 4938 4935 4938 <td xmlns:xlink="http://www.w3.org/1999/xlink">FL2</td>
###xml 4946 4947 4946 4947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 4938 4947 4938 4947 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">370 (50)<sup>b</sup></td>
###xml 4955 4956 4955 4956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 4947 4956 4947 4956 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">211 (47)<sup>c</sup></td>
###xml 4956 4960 4956 4960 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.a.</td>
###xml 4960 4966 4960 4966 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">40 (9)</td>
###xml 4966 4976 4966 4976 <td xmlns:xlink="http://www.w3.org/1999/xlink">28.5 (5.5)</td>
###xml 4976 4980 4976 4980 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.a.</td>
###xml 4935 4980 4935 4980 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>FL2</td><td char="(" align="char">370 (50)<sup>b</sup></td><td char="(" align="char">211 (47)<sup>c</sup></td><td>n.a.</td><td char="(" align="char">40 (9)</td><td>28.5 (5.5)</td><td>n.a.</td></tr>
###xml 4980 4983 4980 4983 <td xmlns:xlink="http://www.w3.org/1999/xlink">SE1</td>
###xml 4983 4991 4983 4991 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">468 (52)</td>
###xml 4991 4999 4991 4999 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">480 (53)</td>
###xml 4999 5006 4999 5006 <td xmlns:xlink="http://www.w3.org/1999/xlink">66 (12)</td>
###xml 5006 5013 5006 5013 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">67 (11)</td>
###xml 5013 5023 5013 5023 <td xmlns:xlink="http://www.w3.org/1999/xlink">27.5 (4.1)</td>
###xml 5023 5033 5023 5033 <td xmlns:xlink="http://www.w3.org/1999/xlink">27.9 (4.1)</td>
###xml 4980 5033 4980 5033 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SE1</td><td char="(" align="char">468 (52)</td><td char="(" align="char">480 (53)</td><td>66 (12)</td><td char="(" align="char">67 (11)</td><td>27.5 (4.1)</td><td>27.9 (4.1)</td></tr>
###xml 4507 5033 4507 5033 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>NL1</td><td char="(" align="char">519 (55)</td><td char="(" align="char">480 (52)</td><td>65 (8)</td><td char="(" align="char">67 (8)</td><td>26.4 (4.5)</td><td>28.8 (4.6)</td></tr><tr><td>NL2</td><td char="(" align="char">1,517 (44)</td><td char="(" align="char">821 (50)</td><td>53 (7)</td><td char="(" align="char">61 (11)</td><td>25.5 (3.6)</td><td>29.0 (4.6)</td></tr><tr><td>NL3</td><td char="(" align="char">920 (61)</td><td char="(" align="char">501 (46)</td><td>48 (13)</td><td char="(" align="char">71 (10)</td><td>n.a.</td><td>27.8 (4.1)</td></tr><tr><td>NL4</td><td char="(" align="char">5,183 (41)</td><td char="(" align="char">1,222 (39)</td><td>69 (9)</td><td char="(" align="char">73 (9)</td><td>26.0 (3.9)</td><td>27.4 (4.0)</td></tr><tr><td>DK1</td><td char="(" align="char">514 (46)</td><td char="(" align="char">706 (48)</td><td>57 (10)</td><td char="(" align="char">59 (10)</td><td>25.9 (3.8)</td><td>29.3 (5.1)</td></tr><tr><td>UK1</td><td char="(" align="char">5,126 (51)</td><td char="(" align="char">4,124 (55)</td><td>60 (13)</td><td char="(" align="char">66 (6)</td><td>26.9 (11.4)</td><td>31.2 (13.8)</td></tr><tr><td>UK2</td><td char="(" align="char">10,220 (50)</td><td char="(" align="char">1,853 (61)</td><td>42 (7)</td><td char="(" align="char">57 (9)</td><td>27.2 (6.4)<sup>a</sup></td><td>31.8 (6.7)</td></tr><tr><td>FL1</td><td char="(" align="char">353 (53)</td><td char="(" align="char">402 (55)</td><td>60 (10)</td><td char="(" align="char">61 (10)</td><td>26.1 (3.6)</td><td>28.7 (4.5)</td></tr><tr><td>FL2</td><td char="(" align="char">370 (50)<sup>b</sup></td><td char="(" align="char">211 (47)<sup>c</sup></td><td>n.a.</td><td char="(" align="char">40 (9)</td><td>28.5 (5.5)</td><td>n.a.</td></tr><tr><td>SE1</td><td char="(" align="char">468 (52)</td><td char="(" align="char">480 (53)</td><td>66 (12)</td><td char="(" align="char">67 (11)</td><td>27.5 (4.1)</td><td>27.9 (4.1)</td></tr></tbody>
###xml 4398 5033 4398 5033 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Study</th><th colspan="2">Participants, <italic>n</italic> (% male)</th><th colspan="2">Mean age, years (SD)</th><th colspan="2">Mean BMI , kg/m<sup>2</sup> (SD)</th></tr><tr><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th></tr></thead><tbody><tr><td>NL1</td><td char="(" align="char">519 (55)</td><td char="(" align="char">480 (52)</td><td>65 (8)</td><td char="(" align="char">67 (8)</td><td>26.4 (4.5)</td><td>28.8 (4.6)</td></tr><tr><td>NL2</td><td char="(" align="char">1,517 (44)</td><td char="(" align="char">821 (50)</td><td>53 (7)</td><td char="(" align="char">61 (11)</td><td>25.5 (3.6)</td><td>29.0 (4.6)</td></tr><tr><td>NL3</td><td char="(" align="char">920 (61)</td><td char="(" align="char">501 (46)</td><td>48 (13)</td><td char="(" align="char">71 (10)</td><td>n.a.</td><td>27.8 (4.1)</td></tr><tr><td>NL4</td><td char="(" align="char">5,183 (41)</td><td char="(" align="char">1,222 (39)</td><td>69 (9)</td><td char="(" align="char">73 (9)</td><td>26.0 (3.9)</td><td>27.4 (4.0)</td></tr><tr><td>DK1</td><td char="(" align="char">514 (46)</td><td char="(" align="char">706 (48)</td><td>57 (10)</td><td char="(" align="char">59 (10)</td><td>25.9 (3.8)</td><td>29.3 (5.1)</td></tr><tr><td>UK1</td><td char="(" align="char">5,126 (51)</td><td char="(" align="char">4,124 (55)</td><td>60 (13)</td><td char="(" align="char">66 (6)</td><td>26.9 (11.4)</td><td>31.2 (13.8)</td></tr><tr><td>UK2</td><td char="(" align="char">10,220 (50)</td><td char="(" align="char">1,853 (61)</td><td>42 (7)</td><td char="(" align="char">57 (9)</td><td>27.2 (6.4)<sup>a</sup></td><td>31.8 (6.7)</td></tr><tr><td>FL1</td><td char="(" align="char">353 (53)</td><td char="(" align="char">402 (55)</td><td>60 (10)</td><td char="(" align="char">61 (10)</td><td>26.1 (3.6)</td><td>28.7 (4.5)</td></tr><tr><td>FL2</td><td char="(" align="char">370 (50)<sup>b</sup></td><td char="(" align="char">211 (47)<sup>c</sup></td><td>n.a.</td><td char="(" align="char">40 (9)</td><td>28.5 (5.5)</td><td>n.a.</td></tr><tr><td>SE1</td><td char="(" align="char">468 (52)</td><td char="(" align="char">480 (53)</td><td>66 (12)</td><td char="(" align="char">67 (11)</td><td>27.5 (4.1)</td><td>27.9 (4.1)</td></tr></tbody></table>
###xml 5033 5034 5033 5034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 5074 5075 5074 5075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 5165 5166 5165 5166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 5033 5175 5033 5175 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18"><sup>a</sup>Based on the British 1958 Birth Cohort (<italic>n</italic>&#8201;=&#8201;7,133) and Panel 2 of the United Kingdom Blood Services Collection of Common Controls (<italic>n</italic>&#8201;=&#8201;1,643)</p>
###xml 5175 5176 5175 5176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 5175 5183 5175 5183 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19"><sup>b</sup>Parents</p>
###xml 5183 5184 5183 5184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 5183 5192 5183 5192 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20"><sup>c</sup>Probands</p>
###xml 5192 5211 5192 5211 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">n.a., not available</p>
###xml 5033 5211 5033 5211 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18"><sup>a</sup>Based on the British 1958 Birth Cohort (<italic>n</italic>&#8201;=&#8201;7,133) and Panel 2 of the United Kingdom Blood Services Collection of Common Controls (<italic>n</italic>&#8201;=&#8201;1,643)</p><p textid="19"><sup>b</sup>Parents</p><p textid="20"><sup>c</sup>Probands</p><p textid="21">n.a., not available</p></table-wrap-foot>
###xml 4363 5211 4363 5211 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="17">Description of study samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Study</th><th colspan="2">Participants, <italic>n</italic> (% male)</th><th colspan="2">Mean age, years (SD)</th><th colspan="2">Mean BMI , kg/m<sup>2</sup> (SD)</th></tr><tr><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th><th>Controls</th><th>Cases</th></tr></thead><tbody><tr><td>NL1</td><td char="(" align="char">519 (55)</td><td char="(" align="char">480 (52)</td><td>65 (8)</td><td char="(" align="char">67 (8)</td><td>26.4 (4.5)</td><td>28.8 (4.6)</td></tr><tr><td>NL2</td><td char="(" align="char">1,517 (44)</td><td char="(" align="char">821 (50)</td><td>53 (7)</td><td char="(" align="char">61 (11)</td><td>25.5 (3.6)</td><td>29.0 (4.6)</td></tr><tr><td>NL3</td><td char="(" align="char">920 (61)</td><td char="(" align="char">501 (46)</td><td>48 (13)</td><td char="(" align="char">71 (10)</td><td>n.a.</td><td>27.8 (4.1)</td></tr><tr><td>NL4</td><td char="(" align="char">5,183 (41)</td><td char="(" align="char">1,222 (39)</td><td>69 (9)</td><td char="(" align="char">73 (9)</td><td>26.0 (3.9)</td><td>27.4 (4.0)</td></tr><tr><td>DK1</td><td char="(" align="char">514 (46)</td><td char="(" align="char">706 (48)</td><td>57 (10)</td><td char="(" align="char">59 (10)</td><td>25.9 (3.8)</td><td>29.3 (5.1)</td></tr><tr><td>UK1</td><td char="(" align="char">5,126 (51)</td><td char="(" align="char">4,124 (55)</td><td>60 (13)</td><td char="(" align="char">66 (6)</td><td>26.9 (11.4)</td><td>31.2 (13.8)</td></tr><tr><td>UK2</td><td char="(" align="char">10,220 (50)</td><td char="(" align="char">1,853 (61)</td><td>42 (7)</td><td char="(" align="char">57 (9)</td><td>27.2 (6.4)<sup>a</sup></td><td>31.8 (6.7)</td></tr><tr><td>FL1</td><td char="(" align="char">353 (53)</td><td char="(" align="char">402 (55)</td><td>60 (10)</td><td char="(" align="char">61 (10)</td><td>26.1 (3.6)</td><td>28.7 (4.5)</td></tr><tr><td>FL2</td><td char="(" align="char">370 (50)<sup>b</sup></td><td char="(" align="char">211 (47)<sup>c</sup></td><td>n.a.</td><td char="(" align="char">40 (9)</td><td>28.5 (5.5)</td><td>n.a.</td></tr><tr><td>SE1</td><td char="(" align="char">468 (52)</td><td char="(" align="char">480 (53)</td><td>66 (12)</td><td char="(" align="char">67 (11)</td><td>27.5 (4.1)</td><td>27.9 (4.1)</td></tr></tbody></table><table-wrap-foot><p textid="18"><sup>a</sup>Based on the British 1958 Birth Cohort (<italic>n</italic>&#8201;=&#8201;7,133) and Panel 2 of the United Kingdom Blood Services Collection of Common Controls (<italic>n</italic>&#8201;=&#8201;1,643)</p><p textid="19"><sup>b</sup>Parents</p><p textid="20"><sup>c</sup>Probands</p><p textid="21">n.a., not available</p></table-wrap-foot></table-wrap>
###xml 410 422 <span type="species:ncbi:9606">participants</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
###xml 904 912 <span type="species:ncbi:9606">patients</span>
###xml 1139 1147 <span type="species:ncbi:9606">patients</span>
###xml 1338 1350 <span type="species:ncbi:9606">participants</span>
###xml 1405 1417 <span type="species:ncbi:9606">participants</span>
###xml 1875 1887 <span type="species:ncbi:9606">participants</span>
###xml 1914 1922 <span type="species:ncbi:9606">patients</span>
###xml 2080 2088 <span type="species:ncbi:9606">patients</span>
###xml 2728 2736 <span type="species:ncbi:9606">patients</span>
###xml 2788 2800 <span type="species:ncbi:9606">participants</span>
###xml 3001 3009 <span type="species:ncbi:9606">patients</span>
###xml 3355 3363 <span type="species:ncbi:9606">patients</span>
###xml 3989 3997 <span type="species:ncbi:9606">patients</span>
###xml 4134 4142 <span type="species:ncbi:9606">patients</span>
###xml 5263 5271 <span type="species:ncbi:9606">patients</span>
###xml 5481 5493 <span type="species:ncbi:9606">participants</span>
Study samples The first part of our study aimed to identify common alleles associated with increased type 2 diabetes susceptibility using DIAGRAM consortium data and a tagging SNP approach. For this we genotyped several European samples.The first sample was from the Hoorn Study (NL1) [7], a Dutch population-based study from the city of Hoorn, in the north-west of the Netherlands, from which we selected 519 participants with normal glucose tolerance (NGT) and 480 type 2 diabetes patients. Glucose tolerance was assessed using a fasting OGTT, according to 1999 WHO criteria [8]. This sample was used to analyse common variation in LARS2 gene with a tagging SNP approach. Variants in LARS2 identified from the DIAGRAM meta-analysis and the tagging SNP approach were then taken forward for replication in three Dutch samples.The second Dutch sample (NL2) included 1,517 controls and 821 type 2 diabetic patients [9, 10]. The 1,517 controls were randomly selected from the New Hoorn Study (NHS), which is an ongoing, population-based study from the city of Hoorn which does not overlap with the original NL1 sample. Of the type 2 diabetes patients, 147 were from the NHS and the remainder (n = 674) were recruited from the diabetes clinics of the Leiden University Medical Centre and the Vrije Universiteit medical centre, Amsterdam. All participants in this replication sample were Dutch whites. All NGT participants underwent an OGTT and were classified according to WHO criteria [8].The third replication sample was ascertained from the Breda study (NL3) [11, 12]. This is a case-control study from the city of Breda, in the south of the Netherlands. The 920 controls were from the Dutch blood bank and self-reported a non-diabetic state. The 501 cases had type 2 diabetes diagnosed on the basis of WHO criteria [8].For the fourth replication sample we selected 5,183 NGT participants and 1,222 type 2 diabetes patients from the population-based ERGO study (NL4) from Rotterdam in the south-west region of the Netherlands [13].In total 8,139 controls and 3,024 type 2 diabetes patients were included in our replication study in the Netherlands.The second part of this study was focused on the follow up of two low-frequency variants in LARS2, for which we carried out replication in samples from the Netherlands (NL1-NL4) as well as samples from the UK (UK sample 1 [UK1], UK sample 2 [UK2]), Denmark (Denmark sample 1 [DK1]), Finland (Finland sample 1 [FL1], Finland sample 2 [FL2]) and Sweden (Sweden [SE1]).Our DK1 sample [14] consisted of 514 NGT controls randomly selected from public registers at the Steno Diabetes Center and the Research Centre for Prevention and Health, Copenhagen, Denmark. The 706 type 2 diabetes patients were recruited from the Steno Diabetes Center. NGT participants underwent an OGTT according to WHO criteria [8].Of the two UK samples, the first (UK1) was the United Kingdom Type 2 Diabetes Genetics Consortium case-control sample, comprising 4,124 type 2 diabetes patients and 5,126 controls ascertained in Tayside, Scotland. Details of the ascertainment scheme and recruitment criteria for this sample have been described elsewhere [15, 16]. The enlarged sample used here represents continuing recruitment to this resource under precisely the same criteria. The second sample, UK2, consisted of 1,853 type 2 diabetes patients ascertained as part of the BDA Warren 2 collection (Exeter, London, Oxford, Norwich and Newcastle) and 10,220 control samples. The latter represent the full British 1,958 Birth Cohort (n = 7,133) and the United Kingdom Blood Services Collection of Common Controls (n = 3,087), a subset of which featured in the Wellcome Trust Case Control Consortium (WTCCC) genome-wide association scan (both samples were collected throughout the UK) [15, 16].Finally, we included samples from Finland and Sweden. The FL1 sample was a case-control sample from the Botnia region of Finland, consisting of 353 controls and 402 type 2 diabetes patients. The sample from Sweden, SE1, was from a case-control study from Skara and Malmo, and consisted of 468 controls and 480 type 2 diabetes patients. We also included a set of trios originating from the Botnia region of Finland. This sample, FL2, consisted of 211 probands (multiple diabetic sibs) and 370 parents [17, 18]. All study samples are summarised in Table 1. Table 1Description of study samplesStudyParticipants, n (% male)Mean age, years (SD)Mean BMI , kg/m2 (SD)ControlsCasesControlsCasesControlsCasesNL1519 (55)480 (52)65 (8)67 (8)26.4 (4.5)28.8 (4.6)NL21,517 (44)821 (50)53 (7)61 (11)25.5 (3.6)29.0 (4.6)NL3920 (61)501 (46)48 (13)71 (10)n.a.27.8 (4.1)NL45,183 (41)1,222 (39)69 (9)73 (9)26.0 (3.9)27.4 (4.0)DK1514 (46)706 (48)57 (10)59 (10)25.9 (3.8)29.3 (5.1)UK15,126 (51)4,124 (55)60 (13)66 (6)26.9 (11.4)31.2 (13.8)UK210,220 (50)1,853 (61)42 (7)57 (9)27.2 (6.4)a31.8 (6.7)FL1353 (53)402 (55)60 (10)61 (10)26.1 (3.6)28.7 (4.5)FL2370 (50)b211 (47)cn.a.40 (9)28.5 (5.5)n.a.SE1468 (52)480 (53)66 (12)67 (11)27.5 (4.1)27.9 (4.1)aBased on the British 1958 Birth Cohort (n = 7,133) and Panel 2 of the United Kingdom Blood Services Collection of Common Controls (n = 1,643)bParentscProbandsn.a., not availableIn total 25,191 controls and 10,800 type 2 diabetes patients were included for follow up of the low-frequency variants.All studies were approved by the appropriate medical ethical committees and were in accordance with the principles of the Declaration of Helsinki. All participants provided written, informed consent for this study.
###end p 16
###begin p 17
Description of study samples
###end p 17
###begin p 18
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
aBased on the British 1958 Birth Cohort (n = 7,133) and Panel 2 of the United Kingdom Blood Services Collection of Common Controls (n = 1,643)
###end p 18
###begin p 19
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bParents
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cProbands
###end p 20
###begin p 21
n.a., not available
###end p 21
###begin p 22
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Common SNP selection</bold>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 513 514 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
Common SNP selection Common SNPs (minor allele frequency [MAF] >5%) in the LARS2 locus were selected for follow-up based on data from the DIAGRAM meta-analysis (gene boundaries chr3: 45373001 ... 45698001) [19]. SNPs with a p < 0.05 were genotyped in the Dutch replication samples (NL1-NL4). Furthermore, tagging SNPs in LARS2 were selected for genotyping in the NL1 sample using the HapMap database and Tagger software [20, 21] (selection criteria and SNPs shown in Electronic supplementary material [ESM] Table 1).
###end p 22
###begin p 23
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genotyping and quality control</bold>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Genotyping and quality control SNPs selected for follow-up in our replication samples were genotyped using Taqman SNP genotyping assays (Applied Biosystems, Foster City, CA, USA). Tagging SNPs were genotyped in the NL1 sample using the Sequenom platform (Sequenom, San Diego, CA, USA). Assays showing overlapping clusters, success rates below 95% or not obeying Hardy-Weinberg equilibrium (p < 0.05) were excluded from analysis. Duplicate samples (approximately5%) showed complete concordance.
###end p 23
###begin p 24
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Statistical analysis</bold>
###xml 103 106 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#967;</italic>
###xml 106 107 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 992 994 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1109 1110 1107 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1245 1247 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1499 1501 1483 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1780 1781 1756 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2108 2109 2084 2085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 2354 2355 2326 2327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 414 426 <span type="species:ncbi:9606">participants</span>
###xml 2906 2914 <span type="species:ncbi:9606">patients</span>
Statistical analysis Differences in genotype distribution and allele frequencies were analysed using a chi2 test. Odds ratios were calculated using an additive model, which was the best fit for the data. Homogeneity of ORs between the different samples was calculated with a Tarone's test, after which a common OR was calculated with a Mantel-Haenszel test using a fixed effects model. Results from OGTT (only NGT participants) were analysed with univariate analysis of variance, using additive, recessive and dominant models, and correction for age, BMI and sex as possible confounders. Association was assessed by the transmission disequilibrium test in the Botnia trios. All general statistics were calculated using SPSS 16.0 (SPSS, Chicago, IL, USA). For statistics involving the geographical distribution of the H324Q (rs71645922) variant in the UK population (described below), we used StatXact v 6.0 (Cytel Software, Cambridge, MA, USA).Power calculations were performed using Quanto [22]. From the DIAGRAM consortium meta-analysis of common variants we selected for replication all common SNPs with a p < 0.05. At this alpha, the DIAGRAM consortium meta-analysis had at least 80% power to detect a variant with OR >/= 1.20 (MAF > 0.05) [22]. Combined with our Dutch replication sample, we had at least 80% power to replicate the association of a variant with an OR >/= 1.09 at the observed MAFs of 0.19 (rs952621) and 0.24 (rs17637703) respectively (alpha = 0.05 or OR >/= 1.12 at alpha = 10-4). Power of the tagging SNP approach in NL1 was limited (80% power to detect a variant with an OR >/= 1.6 [alpha = 0.05, MAF = 0.05] or OR >/= 1.45 at the observed lowest MAF of 0.10). Therefore we replicated in NL2-NL4 only our strongest signal from the NL1 sample (rs17637703, p = 0.07).While extensive GWAS have indicated that the effect sizes of common variants influencing type 2 diabetes risk are modest, the potential remains for low-frequency variants to have effects on type 2 diabetes risk that are more substantial, which was corroborated by our previous observation regarding the H324Q variant [6]. Power calculations at the start of the project demonstrated that we had at least 99% power to detect an effect size similar to our initial finding for H324Q (rs71645922) (OR 1.4) and at least 80% power to detect an OR of 1.13 (alpha = 0.05) [6]. From the DIAGRAM meta-analysis we used an alpha of 0.05 to select other low-frequency SNPs for replication. At this alpha, the power in DIAGRAM was 80% to detect association for variants with ORs ranging from 1.24 (MAF = 0.03) to 1.45 (MAF = 0.01 and alpha = 0.05). For replication of the two low-frequency variants (observed MAFs approximately0.03 [H324Q, rs71645922] and approximately0.05 [rs9825041] respectively), we had in our complete replication sample at least 80% power to detect an OR >/= 1.13 (25,191 controls and 10,800 type 2 diabetes patients, alpha = 0.05).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Common LARS2 variants in available DIAGRAM GWAS data </bold>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 599 600 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 766 767 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 776 777 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 913 918 913 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 1074 1075 1074 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 1178 1179 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1285 1286 1285 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1295 1296 1295 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Common LARS2 variants in available DIAGRAM GWAS data  We analysed the data from the DIAGRAM GWAS meta-analysis [19] for the LARS2 gene (100% coverage [MAF > 5%], according to HapMap phase 2, April 2007, Centre d'Etude du Polymorphisme [Utah residents with northern and western European ancestry] [CEU] population) and observed one common SNP (rs952621, directly typed) showing weak evidence of association with type 2 diabetes (OR 1.11 [95% CI 1.02-1.20], p = 0.01 for the T allele). This SNP was also captured in our complementary tagging SNP approach (NL1), with an OR of 1.13 [95% CI 0.89-1.43], p = 0.33 for the same allele. However, additional genotyping in the Dutch samples (NL2, NL4) and meta-analysis of all data resulted in a common OR of 1.05 (0.99-1.11, p = 0.13, n = 19,870). As there was no convincing evidence of association in our samples, this SNP was not analysed further.No other common SNP in LARS2 showed evidence of association with type 2 diabetes in the GWAS data. The same was true of the tagging SNP analysis conducted in the NL1 sample (ESM Table 1). In the latter analysis, rs17637703 showed weak evidence of association (OR 1.22 [95% CI 0.99-1.50], p = 0.07), but this was not confirmed in the Dutch replication samples (common OR 0.98 [95% CI 0.91-1.06], p = 0.62, n = 10,087), in line with the DIAGRAM result for this SNP (OR 1.02 [0.94-1.10]).
###end p 26
###begin p 27
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Low-frequency variants in LARS2</bold>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">1</xref>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 772 779 772 779 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 779 834 779 834 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Genotyping results for rs9825041 and H324Q (rs71645922)</p>
###xml 779 834 779 834 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Genotyping results for rs9825041 and H324Q (rs71645922)</p></caption>
###xml 834 840 834 840 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Sample</th>
###xml 840 854 840 854 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Controls/cases</th>
###xml 854 863 854 863 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">rs9825041</th>
###xml 863 881 863 881 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">H324Q (rs71645922)</th>
###xml 834 881 834 881 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Sample</th><th rowspan="2">Controls/cases</th><th colspan="4">rs9825041</th><th colspan="4">H324Q (rs71645922)</th></tr>
###xml 881 897 881 897 <th xmlns:xlink="http://www.w3.org/1999/xlink">MAF controls (%)</th>
###xml 897 910 897 910 <th xmlns:xlink="http://www.w3.org/1999/xlink">MAF cases (%)</th>
###xml 910 921 910 921 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 921 922 921 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 922 925 922 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Add</sub>
###xml 921 925 921 925 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic><sub>Add</sub></th>
###xml 925 941 925 941 <th xmlns:xlink="http://www.w3.org/1999/xlink">MAF controls (%)</th>
###xml 941 954 941 954 <th xmlns:xlink="http://www.w3.org/1999/xlink">MAF cases (%)</th>
###xml 954 965 954 965 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 965 966 965 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 966 969 966 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Add</sub>
###xml 965 969 965 969 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic><sub>Add</sub></th>
###xml 881 969 881 969 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th></tr>
###xml 834 969 834 969 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Sample</th><th rowspan="2">Controls/cases</th><th colspan="4">rs9825041</th><th colspan="4">H324Q (rs71645922)</th></tr><tr><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th></tr></thead>
###xml 969 972 969 972 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL1</td>
###xml 972 979 972 979 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">519/480</td>
###xml 979 982 979 982 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.5</td>
###xml 982 985 982 985 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.3</td>
###xml 985 1001 985 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.35 (0.92&#8211;1.98)</td>
###xml 1001 1005 1001 1005 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.15</td>
###xml 1005 1008 1005 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.9</td>
###xml 1008 1011 1008 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.3</td>
###xml 1027 1028 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1011 1028 1011 1028 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.26 (1.10&#8211;4.66)<sup>a</sup></td>
###xml 1028 1032 1028 1032 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.04</td>
###xml 969 1032 969 1032 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL1</td><td char="/" align="char">519/480</td><td>5.5</td><td>7.3</td><td>1.35 (0.92&#8211;1.98)</td><td>0.15</td><td char="." align="char">1.9</td><td char="." align="char">4.3</td><td>2.26 (1.10&#8211;4.66)<sup>a</sup></td><td>0.04</td></tr>
###xml 1032 1035 1032 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL2</td>
###xml 1035 1044 1035 1044 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">1,517/821</td>
###xml 1044 1047 1044 1047 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.0</td>
###xml 1047 1050 1047 1050 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.6</td>
###xml 1050 1066 1050 1066 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.11 (0.85&#8211;1.44)</td>
###xml 1066 1070 1066 1070 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.46</td>
###xml 1070 1073 1070 1073 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.4</td>
###xml 1073 1076 1073 1076 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.7</td>
###xml 1076 1092 1076 1092 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.78 (0.49&#8211;1.25)</td>
###xml 1092 1096 1092 1096 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.18</td>
###xml 1032 1096 1032 1096 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL2</td><td char="/" align="char">1,517/821</td><td>6.0</td><td>6.6</td><td>1.11 (0.85&#8211;1.44)</td><td>0.46</td><td char="." align="char">3.4</td><td char="." align="char">2.7</td><td>0.78 (0.49&#8211;1.25)</td><td>0.18</td></tr>
###xml 1096 1099 1096 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL3</td>
###xml 1099 1106 1099 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">920/501</td>
###xml 1106 1109 1106 1109 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.7</td>
###xml 1109 1112 1109 1112 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.8</td>
###xml 1112 1128 1112 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.21 (0.88&#8211;1.66)</td>
###xml 1128 1132 1128 1132 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.25</td>
###xml 1132 1135 1132 1135 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.3</td>
###xml 1135 1138 1135 1138 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.0</td>
###xml 1138 1154 1138 1154 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.90 (0.57&#8211;1.41)</td>
###xml 1154 1158 1154 1158 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.74</td>
###xml 1096 1158 1096 1158 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL3</td><td char="/" align="char">920/501</td><td>5.7</td><td>6.8</td><td>1.21 (0.88&#8211;1.66)</td><td>0.25</td><td char="." align="char">3.3</td><td char="." align="char">3.0</td><td>0.90 (0.57&#8211;1.41)</td><td>0.74</td></tr>
###xml 1158 1161 1158 1161 <td xmlns:xlink="http://www.w3.org/1999/xlink">NL4</td>
###xml 1161 1172 1161 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">5,183/1,222</td>
###xml 1172 1175 1172 1175 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.1</td>
###xml 1175 1178 1175 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.5</td>
###xml 1178 1194 1178 1194 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.89 (0.74&#8211;1.08)</td>
###xml 1194 1198 1194 1198 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.27</td>
###xml 1198 1201 1198 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.1</td>
###xml 1201 1204 1201 1204 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.5</td>
###xml 1220 1221 1220 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1204 1221 1204 1221 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.11 (0.84&#8211;1.47)<sup>a</sup></td>
###xml 1221 1225 1221 1225 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.47</td>
###xml 1158 1225 1158 1225 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NL4</td><td char="/" align="char">5,183/1,222</td><td>6.1</td><td>5.5</td><td>0.89 (0.74&#8211;1.08)</td><td>0.27</td><td char="." align="char">3.1</td><td char="." align="char">3.5</td><td>1.11 (0.84&#8211;1.47)<sup>a</sup></td><td>0.47</td></tr>
###xml 1225 1228 1225 1228 <td xmlns:xlink="http://www.w3.org/1999/xlink">DK1</td>
###xml 1228 1235 1228 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">514/706</td>
###xml 1235 1238 1235 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.2</td>
###xml 1238 1241 1238 1241 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.7</td>
###xml 1241 1257 1241 1257 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.12 (0.75&#8211;1.68)</td>
###xml 1257 1261 1257 1261 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.62</td>
###xml 1261 1264 1261 1264 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.2</td>
###xml 1264 1267 1264 1267 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.8</td>
###xml 1283 1284 1283 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1267 1284 1267 1284 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.24 (0.74&#8211;2.09)<sup>a</sup></td>
###xml 1284 1288 1284 1288 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.44</td>
###xml 1225 1288 1225 1288 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DK1</td><td char="/" align="char">514/706</td><td>4.2</td><td>4.7</td><td>1.12 (0.75&#8211;1.68)</td><td>0.62</td><td char="." align="char">2.2</td><td char="." align="char">2.8</td><td>1.24 (0.74&#8211;2.09)<sup>a</sup></td><td>0.44</td></tr>
###xml 1288 1291 1288 1291 <td xmlns:xlink="http://www.w3.org/1999/xlink">DK2</td>
###xml 1291 1300 1291 1300 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">4,501/654</td>
###xml 1300 1304 1300 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1304 1308 1304 1308 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1308 1312 1308 1312 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1312 1316 1312 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1316 1319 1316 1319 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.8</td>
###xml 1319 1322 1319 1322 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.7</td>
###xml 1338 1339 1338 1339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1322 1339 1322 1339 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.33 (0.97&#8211;1.82)<sup>a</sup></td>
###xml 1339 1343 1339 1343 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.08</td>
###xml 1288 1343 1288 1343 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DK2</td><td char="/" align="char">4,501/654</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">2.8</td><td char="." align="char">3.7</td><td>1.33 (0.97&#8211;1.82)<sup>a</sup></td><td>0.08</td></tr>
###xml 1343 1346 1343 1346 <td xmlns:xlink="http://www.w3.org/1999/xlink">UK1</td>
###xml 1346 1357 1346 1357 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">5,126/4,124</td>
###xml 1357 1360 1357 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.9</td>
###xml 1360 1363 1360 1363 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.9</td>
###xml 1363 1379 1363 1379 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.00 (0.87&#8211;1.14)</td>
###xml 1379 1383 1379 1383 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.00</td>
###xml 1383 1386 1383 1386 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.8</td>
###xml 1386 1389 1386 1389 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.4</td>
###xml 1389 1405 1389 1405 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.91 (0.79&#8211;1.05)</td>
###xml 1405 1409 1405 1409 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.19</td>
###xml 1343 1409 1343 1409 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UK1</td><td char="/" align="char">5,126/4,124</td><td>4.9</td><td>4.9</td><td>1.00 (0.87&#8211;1.14)</td><td>1.00</td><td char="." align="char">4.8</td><td char="." align="char">4.4</td><td>0.91 (0.79&#8211;1.05)</td><td>0.19</td></tr>
###xml 1409 1412 1409 1412 <td xmlns:xlink="http://www.w3.org/1999/xlink">UK2</td>
###xml 1412 1424 1412 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">10,220/1,853</td>
###xml 1424 1427 1424 1427 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.8</td>
###xml 1427 1430 1427 1430 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.1</td>
###xml 1430 1446 1430 1446 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.05 (0.88&#8211;1.27)</td>
###xml 1446 1450 1446 1450 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.57</td>
###xml 1450 1453 1450 1453 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.6</td>
###xml 1453 1456 1453 1456 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.4</td>
###xml 1456 1472 1456 1472 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.94 (0.77&#8211;1.15)</td>
###xml 1472 1476 1472 1476 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.59</td>
###xml 1409 1476 1409 1476 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UK2</td><td char="/" align="char">10,220/1,853</td><td>4.8</td><td>5.1</td><td>1.05 (0.88&#8211;1.27)</td><td>0.57</td><td char="." align="char">3.6</td><td char="." align="char">3.4</td><td>0.94 (0.77&#8211;1.15)</td><td>0.59</td></tr>
###xml 1476 1479 1476 1479 <td xmlns:xlink="http://www.w3.org/1999/xlink">FL1</td>
###xml 1479 1486 1479 1486 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">353/402</td>
###xml 1486 1490 1486 1490 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1490 1494 1490 1494 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1494 1498 1494 1498 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1498 1502 1498 1502 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1502 1505 1502 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.2</td>
###xml 1505 1508 1505 1508 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.9</td>
###xml 1508 1524 1508 1524 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.18 (0.72&#8211;1.93)</td>
###xml 1524 1528 1524 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.51</td>
###xml 1476 1528 1476 1528 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>FL1</td><td char="/" align="char">353/402</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.2</td><td char="." align="char">4.9</td><td>1.18 (0.72&#8211;1.93)</td><td>0.51</td></tr>
###xml 1528 1531 1528 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink">SE1</td>
###xml 1531 1538 1531 1538 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="/" align="char">468/480</td>
###xml 1538 1542 1538 1542 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1542 1546 1542 1546 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1546 1550 1546 1550 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1550 1554 1550 1554 <td xmlns:xlink="http://www.w3.org/1999/xlink">n.m.</td>
###xml 1554 1557 1554 1557 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.5</td>
###xml 1557 1560 1557 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.2</td>
###xml 1560 1576 1560 1576 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.94 (0.59&#8211;1.48)</td>
###xml 1576 1580 1576 1580 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.79</td>
###xml 1528 1580 1528 1580 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SE1</td><td char="/" align="char">468/480</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.5</td><td char="." align="char">4.2</td><td>0.94 (0.59&#8211;1.48)</td><td>0.79</td></tr>
###xml 1580 1593 1580 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink">Meta-analysis</td>
###xml 1593 1593 1593 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1593 1593 1593 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1593 1593 1593 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1593 1609 1593 1609 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.03 (0.95&#8211;1.12)</td>
###xml 1609 1613 1609 1613 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.48</td>
###xml 1613 1613 1613 1613 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1613 1613 1613 1613 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1613 1629 1613 1629 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.99 (0.90&#8211;1.08)</td>
###xml 1629 1633 1629 1633 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.82</td>
###xml 1580 1633 1580 1633 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Meta-analysis</td><td/><td/><td/><td>1.03 (0.95&#8211;1.12)</td><td>0.48</td><td/><td/><td>0.99 (0.90&#8211;1.08)</td><td>0.82</td></tr>
###xml 1645 1646 1645 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1633 1646 1633 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink">DIAGRAM GWAS<sup>b</sup></td>
###xml 1646 1646 1646 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1646 1646 1646 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1646 1646 1646 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1646 1662 1646 1662 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.20 (1.03&#8211;1.39)</td>
###xml 1662 1666 1662 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.02</td>
###xml 1666 1666 1666 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1666 1666 1666 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1666 1668 1666 1668 <td xmlns:xlink="http://www.w3.org/1999/xlink">NM</td>
###xml 1668 1670 1668 1670 <td xmlns:xlink="http://www.w3.org/1999/xlink">NM</td>
###xml 1633 1670 1633 1670 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DIAGRAM GWAS<sup>b</sup></td><td/><td/><td/><td>1.20 (1.03&#8211;1.39)</td><td>0.02</td><td/><td/><td>NM</td><td>NM</td></tr>
###xml 969 1670 969 1670 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>NL1</td><td char="/" align="char">519/480</td><td>5.5</td><td>7.3</td><td>1.35 (0.92&#8211;1.98)</td><td>0.15</td><td char="." align="char">1.9</td><td char="." align="char">4.3</td><td>2.26 (1.10&#8211;4.66)<sup>a</sup></td><td>0.04</td></tr><tr><td>NL2</td><td char="/" align="char">1,517/821</td><td>6.0</td><td>6.6</td><td>1.11 (0.85&#8211;1.44)</td><td>0.46</td><td char="." align="char">3.4</td><td char="." align="char">2.7</td><td>0.78 (0.49&#8211;1.25)</td><td>0.18</td></tr><tr><td>NL3</td><td char="/" align="char">920/501</td><td>5.7</td><td>6.8</td><td>1.21 (0.88&#8211;1.66)</td><td>0.25</td><td char="." align="char">3.3</td><td char="." align="char">3.0</td><td>0.90 (0.57&#8211;1.41)</td><td>0.74</td></tr><tr><td>NL4</td><td char="/" align="char">5,183/1,222</td><td>6.1</td><td>5.5</td><td>0.89 (0.74&#8211;1.08)</td><td>0.27</td><td char="." align="char">3.1</td><td char="." align="char">3.5</td><td>1.11 (0.84&#8211;1.47)<sup>a</sup></td><td>0.47</td></tr><tr><td>DK1</td><td char="/" align="char">514/706</td><td>4.2</td><td>4.7</td><td>1.12 (0.75&#8211;1.68)</td><td>0.62</td><td char="." align="char">2.2</td><td char="." align="char">2.8</td><td>1.24 (0.74&#8211;2.09)<sup>a</sup></td><td>0.44</td></tr><tr><td>DK2</td><td char="/" align="char">4,501/654</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">2.8</td><td char="." align="char">3.7</td><td>1.33 (0.97&#8211;1.82)<sup>a</sup></td><td>0.08</td></tr><tr><td>UK1</td><td char="/" align="char">5,126/4,124</td><td>4.9</td><td>4.9</td><td>1.00 (0.87&#8211;1.14)</td><td>1.00</td><td char="." align="char">4.8</td><td char="." align="char">4.4</td><td>0.91 (0.79&#8211;1.05)</td><td>0.19</td></tr><tr><td>UK2</td><td char="/" align="char">10,220/1,853</td><td>4.8</td><td>5.1</td><td>1.05 (0.88&#8211;1.27)</td><td>0.57</td><td char="." align="char">3.6</td><td char="." align="char">3.4</td><td>0.94 (0.77&#8211;1.15)</td><td>0.59</td></tr><tr><td>FL1</td><td char="/" align="char">353/402</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.2</td><td char="." align="char">4.9</td><td>1.18 (0.72&#8211;1.93)</td><td>0.51</td></tr><tr><td>SE1</td><td char="/" align="char">468/480</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.5</td><td char="." align="char">4.2</td><td>0.94 (0.59&#8211;1.48)</td><td>0.79</td></tr><tr><td>Meta-analysis</td><td/><td/><td/><td>1.03 (0.95&#8211;1.12)</td><td>0.48</td><td/><td/><td>0.99 (0.90&#8211;1.08)</td><td>0.82</td></tr><tr><td>DIAGRAM GWAS<sup>b</sup></td><td/><td/><td/><td>1.20 (1.03&#8211;1.39)</td><td>0.02</td><td/><td/><td>NM</td><td>NM</td></tr></tbody>
###xml 834 1670 834 1670 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Sample</th><th rowspan="2">Controls/cases</th><th colspan="4">rs9825041</th><th colspan="4">H324Q (rs71645922)</th></tr><tr><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th></tr></thead><tbody><tr><td>NL1</td><td char="/" align="char">519/480</td><td>5.5</td><td>7.3</td><td>1.35 (0.92&#8211;1.98)</td><td>0.15</td><td char="." align="char">1.9</td><td char="." align="char">4.3</td><td>2.26 (1.10&#8211;4.66)<sup>a</sup></td><td>0.04</td></tr><tr><td>NL2</td><td char="/" align="char">1,517/821</td><td>6.0</td><td>6.6</td><td>1.11 (0.85&#8211;1.44)</td><td>0.46</td><td char="." align="char">3.4</td><td char="." align="char">2.7</td><td>0.78 (0.49&#8211;1.25)</td><td>0.18</td></tr><tr><td>NL3</td><td char="/" align="char">920/501</td><td>5.7</td><td>6.8</td><td>1.21 (0.88&#8211;1.66)</td><td>0.25</td><td char="." align="char">3.3</td><td char="." align="char">3.0</td><td>0.90 (0.57&#8211;1.41)</td><td>0.74</td></tr><tr><td>NL4</td><td char="/" align="char">5,183/1,222</td><td>6.1</td><td>5.5</td><td>0.89 (0.74&#8211;1.08)</td><td>0.27</td><td char="." align="char">3.1</td><td char="." align="char">3.5</td><td>1.11 (0.84&#8211;1.47)<sup>a</sup></td><td>0.47</td></tr><tr><td>DK1</td><td char="/" align="char">514/706</td><td>4.2</td><td>4.7</td><td>1.12 (0.75&#8211;1.68)</td><td>0.62</td><td char="." align="char">2.2</td><td char="." align="char">2.8</td><td>1.24 (0.74&#8211;2.09)<sup>a</sup></td><td>0.44</td></tr><tr><td>DK2</td><td char="/" align="char">4,501/654</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">2.8</td><td char="." align="char">3.7</td><td>1.33 (0.97&#8211;1.82)<sup>a</sup></td><td>0.08</td></tr><tr><td>UK1</td><td char="/" align="char">5,126/4,124</td><td>4.9</td><td>4.9</td><td>1.00 (0.87&#8211;1.14)</td><td>1.00</td><td char="." align="char">4.8</td><td char="." align="char">4.4</td><td>0.91 (0.79&#8211;1.05)</td><td>0.19</td></tr><tr><td>UK2</td><td char="/" align="char">10,220/1,853</td><td>4.8</td><td>5.1</td><td>1.05 (0.88&#8211;1.27)</td><td>0.57</td><td char="." align="char">3.6</td><td char="." align="char">3.4</td><td>0.94 (0.77&#8211;1.15)</td><td>0.59</td></tr><tr><td>FL1</td><td char="/" align="char">353/402</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.2</td><td char="." align="char">4.9</td><td>1.18 (0.72&#8211;1.93)</td><td>0.51</td></tr><tr><td>SE1</td><td char="/" align="char">468/480</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.5</td><td char="." align="char">4.2</td><td>0.94 (0.59&#8211;1.48)</td><td>0.79</td></tr><tr><td>Meta-analysis</td><td/><td/><td/><td>1.03 (0.95&#8211;1.12)</td><td>0.48</td><td/><td/><td>0.99 (0.90&#8211;1.08)</td><td>0.82</td></tr><tr><td>DIAGRAM GWAS<sup>b</sup></td><td/><td/><td/><td>1.20 (1.03&#8211;1.39)</td><td>0.02</td><td/><td/><td>NM</td><td>NM</td></tr></tbody></table>
###xml 1670 1671 1670 1671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1711 1712 1711 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1781 1782 1781 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1670 1789 1670 1789 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><sup>a</sup>Data from previously published results [<xref ref-type="bibr" rid="CR6">6</xref>]; results from NL4 study are partially from this previous research (<italic>n</italic>&#8201;=&#8201;914)</p>
###xml 1789 1790 1789 1790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1836 1837 1836 1837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1897 1899 1897 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 1789 1900 1789 1900 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><sup>b</sup>Meta-analysis of the DIAGRAM consortium GWAS, <italic>n</italic>&#8201;=&#8201;10,128 (4,549 type 2 diabetic patients, 5,579 controls) [<xref ref-type="bibr" rid="CR19">19</xref>]</p>
###xml 1900 1918 1900 1918 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">n.m., not measured</p>
###xml 1918 1919 1918 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1919 1922 1919 1922 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Add</sub>
###xml 1924 1925 1924 1925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1918 1947 1918 1947 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><italic>p</italic><sub>Add</sub>, <italic>p</italic> value, additive model</p>
###xml 1670 1947 1670 1947 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><sup>a</sup>Data from previously published results [<xref ref-type="bibr" rid="CR6">6</xref>]; results from NL4 study are partially from this previous research (<italic>n</italic>&#8201;=&#8201;914)</p><p textid="30"><sup>b</sup>Meta-analysis of the DIAGRAM consortium GWAS, <italic>n</italic>&#8201;=&#8201;10,128 (4,549 type 2 diabetic patients, 5,579 controls) [<xref ref-type="bibr" rid="CR19">19</xref>]</p><p textid="31">n.m., not measured</p><p textid="32"><italic>p</italic><sub>Add</sub>, <italic>p</italic> value, additive model</p></table-wrap-foot>
###xml 772 1947 772 1947 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="28">Genotyping results for rs9825041 and H324Q (rs71645922)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Sample</th><th rowspan="2">Controls/cases</th><th colspan="4">rs9825041</th><th colspan="4">H324Q (rs71645922)</th></tr><tr><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th><th>MAF controls (%)</th><th>MAF cases (%)</th><th>OR (95% CI)</th><th><italic>p</italic><sub>Add</sub></th></tr></thead><tbody><tr><td>NL1</td><td char="/" align="char">519/480</td><td>5.5</td><td>7.3</td><td>1.35 (0.92&#8211;1.98)</td><td>0.15</td><td char="." align="char">1.9</td><td char="." align="char">4.3</td><td>2.26 (1.10&#8211;4.66)<sup>a</sup></td><td>0.04</td></tr><tr><td>NL2</td><td char="/" align="char">1,517/821</td><td>6.0</td><td>6.6</td><td>1.11 (0.85&#8211;1.44)</td><td>0.46</td><td char="." align="char">3.4</td><td char="." align="char">2.7</td><td>0.78 (0.49&#8211;1.25)</td><td>0.18</td></tr><tr><td>NL3</td><td char="/" align="char">920/501</td><td>5.7</td><td>6.8</td><td>1.21 (0.88&#8211;1.66)</td><td>0.25</td><td char="." align="char">3.3</td><td char="." align="char">3.0</td><td>0.90 (0.57&#8211;1.41)</td><td>0.74</td></tr><tr><td>NL4</td><td char="/" align="char">5,183/1,222</td><td>6.1</td><td>5.5</td><td>0.89 (0.74&#8211;1.08)</td><td>0.27</td><td char="." align="char">3.1</td><td char="." align="char">3.5</td><td>1.11 (0.84&#8211;1.47)<sup>a</sup></td><td>0.47</td></tr><tr><td>DK1</td><td char="/" align="char">514/706</td><td>4.2</td><td>4.7</td><td>1.12 (0.75&#8211;1.68)</td><td>0.62</td><td char="." align="char">2.2</td><td char="." align="char">2.8</td><td>1.24 (0.74&#8211;2.09)<sup>a</sup></td><td>0.44</td></tr><tr><td>DK2</td><td char="/" align="char">4,501/654</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">2.8</td><td char="." align="char">3.7</td><td>1.33 (0.97&#8211;1.82)<sup>a</sup></td><td>0.08</td></tr><tr><td>UK1</td><td char="/" align="char">5,126/4,124</td><td>4.9</td><td>4.9</td><td>1.00 (0.87&#8211;1.14)</td><td>1.00</td><td char="." align="char">4.8</td><td char="." align="char">4.4</td><td>0.91 (0.79&#8211;1.05)</td><td>0.19</td></tr><tr><td>UK2</td><td char="/" align="char">10,220/1,853</td><td>4.8</td><td>5.1</td><td>1.05 (0.88&#8211;1.27)</td><td>0.57</td><td char="." align="char">3.6</td><td char="." align="char">3.4</td><td>0.94 (0.77&#8211;1.15)</td><td>0.59</td></tr><tr><td>FL1</td><td char="/" align="char">353/402</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.2</td><td char="." align="char">4.9</td><td>1.18 (0.72&#8211;1.93)</td><td>0.51</td></tr><tr><td>SE1</td><td char="/" align="char">468/480</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td>n.m.</td><td char="." align="char">4.5</td><td char="." align="char">4.2</td><td>0.94 (0.59&#8211;1.48)</td><td>0.79</td></tr><tr><td>Meta-analysis</td><td/><td/><td/><td>1.03 (0.95&#8211;1.12)</td><td>0.48</td><td/><td/><td>0.99 (0.90&#8211;1.08)</td><td>0.82</td></tr><tr><td>DIAGRAM GWAS<sup>b</sup></td><td/><td/><td/><td>1.20 (1.03&#8211;1.39)</td><td>0.02</td><td/><td/><td>NM</td><td>NM</td></tr></tbody></table><table-wrap-foot><p textid="29"><sup>a</sup>Data from previously published results [<xref ref-type="bibr" rid="CR6">6</xref>]; results from NL4 study are partially from this previous research (<italic>n</italic>&#8201;=&#8201;914)</p><p textid="30"><sup>b</sup>Meta-analysis of the DIAGRAM consortium GWAS, <italic>n</italic>&#8201;=&#8201;10,128 (4,549 type 2 diabetic patients, 5,579 controls) [<xref ref-type="bibr" rid="CR19">19</xref>]</p><p textid="31">n.m., not measured</p><p textid="32"><italic>p</italic><sub>Add</sub>, <italic>p</italic> value, additive model</p></table-wrap-foot></table-wrap>
###xml 744 752 <span type="species:ncbi:9606">patients</span>
###xml 1870 1878 <span type="species:ncbi:9606">patients</span>
Low-frequency variants in LARS2 In addition to the common variants, the DIAGRAM meta-analysis also captured fourteen low-frequency SNPs (0.01 > MAF < 0.05) within the LARS2 gene, ten of which are in high linkage disequilibrium with each other (r2 > 0.95 according to HapMap) (ESM Fig. 1) and showed some evidence for association with type 2 diabetes (ORs 1.17-1.21; p 0.02-0.05). We selected rs9825041 (OR 1.20 [95% CI 1.03-1.39], p = 0.02) as a proxy for the group for genotyping in the replication samples, but no association with type 2 diabetes was observed (Table 2). Homogeneity of ORs was tested with a Tarone's test (p = 0.67) and we calculated a common OR across all studies of 1.03 (95% CI 0.95-1.12), p = 0.45 (8,959 type 2 diabetic patients, 23,003 controls). Table 2Genotyping results for rs9825041 and H324Q (rs71645922)SampleControls/casesrs9825041H324Q (rs71645922)MAF controls (%)MAF cases (%)OR (95% CI)pAddMAF controls (%)MAF cases (%)OR (95% CI)pAddNL1519/4805.57.31.35 (0.92-1.98)0.151.94.32.26 (1.10-4.66)a0.04NL21,517/8216.06.61.11 (0.85-1.44)0.463.42.70.78 (0.49-1.25)0.18NL3920/5015.76.81.21 (0.88-1.66)0.253.33.00.90 (0.57-1.41)0.74NL45,183/1,2226.15.50.89 (0.74-1.08)0.273.13.51.11 (0.84-1.47)a0.47DK1514/7064.24.71.12 (0.75-1.68)0.622.22.81.24 (0.74-2.09)a0.44DK24,501/654n.m.n.m.n.m.n.m.2.83.71.33 (0.97-1.82)a0.08UK15,126/4,1244.94.91.00 (0.87-1.14)1.004.84.40.91 (0.79-1.05)0.19UK210,220/1,8534.85.11.05 (0.88-1.27)0.573.63.40.94 (0.77-1.15)0.59FL1353/402n.m.n.m.n.m.n.m.4.24.91.18 (0.72-1.93)0.51SE1468/480n.m.n.m.n.m.n.m.4.54.20.94 (0.59-1.48)0.79Meta-analysis1.03 (0.95-1.12)0.480.99 (0.90-1.08)0.82DIAGRAM GWASb1.20 (1.03-1.39)0.02NMNMaData from previously published results [6]; results from NL4 study are partially from this previous research (n = 914)bMeta-analysis of the DIAGRAM consortium GWAS, n = 10,128 (4,549 type 2 diabetic patients, 5,579 controls) [19]n.m., not measuredpAdd, p value, additive model
###end p 27
###begin p 28
Genotyping results for rs9825041 and H324Q (rs71645922)
###end p 28
###begin p 29
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
aData from previously published results [6]; results from NL4 study are partially from this previous research (n = 914)
###end p 29
###begin p 30
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
bMeta-analysis of the DIAGRAM consortium GWAS, n = 10,128 (4,549 type 2 diabetic patients, 5,579 controls) [19]
###end p 30
###begin p 31
n.m., not measured
###end p 31
###begin p 32
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Add</sub>
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
pAdd, p value, additive model
###end p 32
###begin p 33
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Follow up of the H324Q (rs71645922) variant in LARS2</bold>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 722 723 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 973 974 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1818 1819 1814 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2240 2241 2236 2237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2250 2252 2246 2248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 2617 2619 2613 2615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 2621 2623 2617 2619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 2624 2626 2620 2622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 2951 2952 2947 2948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">2</xref>
###xml 2988 2989 2984 2985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">2</xref>
###xml 3106 3107 3102 3103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3246 3247 3242 3243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">3</xref>
###xml 321 333 <span type="species:ncbi:9606">Participants</span>
###xml 743 755 <span type="species:ncbi:9606">participants</span>
###xml 780 788 <span type="species:ncbi:9606">patients</span>
###xml 1302 1314 <span type="species:ncbi:9606">participants</span>
###xml 2556 2561 <span type="species:ncbi:57788">cline</span>
Follow up of the H324Q (rs71645922) variant in LARS2 Finally, we examined the association of the H324Q (rs71645922) variant with type 2 diabetes in our replication samples NL2 to NL4, UK1 and UK2, SE1 and FL1. This variant was not captured by the GWAS and was not captured by any of the SNPs mentioned above (r2 < 0.17). Participants in the Dutch replication samples included in our original study of this variant were excluded from analysis (n = 914 from NL4 study). The replication samples did not confirm our previously observed association. A meta-analysis of all available studies including our previous data from the Netherlands (NL1) and Denmark (DK1, DK2) [6] resulted in an overall OR of 0.99 (95% CI 0.90-1.08), p = 0.78, n = 35,715 participants (10,399 type 2 diabetes patients) (Table 2). In addition, no significant excess of transmission of the risk allele was observed in the Botnia trios (FL2, transmitted/untransmitted = 18/14, OR 1.29 [95% CI 0.64-2.59], p = 0.48).To investigate possible heterogeneity between the studies, we performed several analyses. For age stratification we created, based on the age distribution in the Dutch samples, the following age strata: </=60 years, 61 to 70 years and >70 years. A decreased frequency of the risk allele was observed in type 2 diabetes participants with increasing age in most but not all samples (data not shown, available on request), but this did not reach statistical significance. We also looked at age at diagnosis of type 2 diabetes and allele frequencies in those with early-onset diabetes (</=45 years) and in those with age at diagnosis above 45 years. Although the allele frequency was slightly higher in those with early-onset diabetes, this was not statistically significant, nor was the age at diagnosis in carriers and non-carriers (all p > 0.05, data not shown). Stratification for sex and BMI (where data available) did not affect the outcome in the Dutch studies (NL1-NL4, data not shown) and was therefore not further investigated.H324Q (rs71645922) shows marked variation in MAF between the various European-descent samples examined (control MAF ranges from 1.9 to 4.8%). In the two large UK control samples, for example, there was a highly significant (p = 5 x 10-7, using an exact implementation of the Cochran-Armitage trend test) difference in allele frequencies between UK1 (recruited exclusively in Scotland) and UK2 (recruited throughout the UK), which made us consider the possibility that this variant showed variation in allele frequency along the south-north cline as previously described in the WTCCC study and others [16, 23-26]. To test this, we used information on the region of ascertainment that was available from the UK 1958 Birth Cohort and UK Blood Service, and analysed genotype frequencies based on subdivisions of the UK into four major regions, namely (1) Scotland, (2) northern England, (3) Midlands and (4) southern England (see ESM Fig. 2). We found some evidence (ESM Fig. 2) for a north-south gradient across the UK (MAF 4.66%, 3.41%, 3.31% and 3.28% from north to south respectively, with p = 0.038, calculated using the Jonckheere-Terpstra Test [StatXact]). No such MAF gradient was observed in other European samples (ESM Fig. 3)
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
We found no evidence of common SNPs in LARS2 being associated with type 2 diabetes in our samples. We therefore conclude that it is unlikely that common SNPs in LARS2 are associated with type 2 diabetes susceptibility.
###end p 35
###begin p 36
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Several low-frequency SNPs, all in high linkage disequilibrium with each other (r2 > 0.95), showed nominal evidence of association with type 2 diabetes in the DIAGRAM meta-analysis. However, we have been unable to confirm this association in our large replication samples from the Netherlands, Denmark and the UK (n = 31,962). We therefore conclude that the nominal p values observed in the GWAS are most likely to be consistent with statistical noise.
###end p 36
###begin p 37
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1062 1063 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1246 1247 1246 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">2</xref>
###xml 1252 1253 1252 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">3</xref>
###xml 709 721 <span type="species:ncbi:9606">participants</span>
The previously observed association of the H324Q (rs71645922) variant in LARS2 with type 2 diabetes was not confirmed in our replication samples (Table 2). Power calculations at the start of the project demonstrated that we had at least 99% power to detect an effect size similar to our initial finding for H324Q (rs71645922) (OR 1.4) and at least 80% power to detect an OR of 1.13. Before excluding the previous association as false, we considered the possibility of heterogeneity, but found no evidence that age, age at diagnosis, BMI and sex were responsible. Another possibility, raised by the evidence for clinal variation in H324Q MAF across the UK, is that the previous association in Dutch and Danish participants reflected the effects of hidden population structure. However, it seems unlikely that population stratification effects were responsible for the original reports of H324Q (rs71645922) associations, as the cases and controls in that study were recruited from the same relatively narrow geographic regions within the Netherlands and Denmark [6]. Also in our additional Dutch replication cohorts we could not detect a MAF gradient across the country. However, there are differences in MAF between different countries (ESM Figs 2 and 3). Migration patterns in the UK appear to reflect an increase in the MAF of H324Q (rs71645922) and therefore this may be a potential migration marker. However, this needs to be demonstrated in other populations. Since stratification for BMI and sex did not affect our result, we can exclude the possibility that these variables confounded our observation. The reason for the discrepancy between our first and current study is likely to be chance.
###end p 37
###begin p 38
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
Three other low-frequency non-synonymous SNPs are present in the LARS2 locus: K727N (rs36054230), E831D (rs9827689) and E868K (rs34965084). However, according to the dbSNP database and our own sequencing efforts [6], these SNPs are only identified in the African population and not polymorphic in the European population. Therefore, these additional non-synonymous variants were not analysed in this study. As our study did not include a thorough resequencing of the complete LARS2 locus, we cannot fully exclude that other, as yet unknown low-frequency variants are present and associated with type 2 diabetes. Results from the 1,000 genomes project () should facilitate a thorough investigation of low-frequency SNPs in LARS2 in the future.
###end p 38
###begin p 39
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARS2</italic>
###xml 194 206 <span type="species:ncbi:9606">participants</span>
In conclusion, our findings do not support the hypothesis that common variants in LARS2 are major type 2 diabetes susceptibility factors. We have also conducted one of the largest (up to 35,715 participants) replication studies for two low-frequency variants for type 2 diabetes susceptibility. These variants also do not play a significant role in type 2 diabetes susceptibility. We therefore conclude that currently known genetic variation in LARS2 does not play an important role in type 2 diabetes susceptibility.
###end p 39
###begin title 40
Electronic Supplementary Material
###end title 40
###begin p 41
Below is the link to the electronic supplementary material.
###end p 41
###begin p 42
(PDF 20 kb)
###end p 42
###begin p 43
(PDF 20 kb)
###end p 43
###begin p 44
(PDF 240 kb)
###end p 44
###begin p 45
(PDF 43 kb)
###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
###xml 1269 1281 <span type="species:ncbi:9606">participants</span>
This study was supported by the Netherlands Organization for Scientific Research, the ZonMW RIDE programme and the Dutch Diabetes Research Foundation. The Danish study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP), the Danish Health Research Council and The European Union (EUGENE2, grant no. LSHM-CT-2004-512013). We acknowledge use of genotype data from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. We thank the staff and senior management of the UK Blood Services responsible for the UK Blood Services Collection. Diabetes UK funded the collection of the Warren 2 resource and the UK Type 2 Diabetes Genetics Consortium collection was supported by the Wellcome Trust (Biomedical Collections Grant GR072960). We also acknowledge funding from Diabetes UK (Grant RD04/0002809), Wellcome Trust (076113 and GR072960), UK Medical Research Council (G0601261) and the Oxford NIHR Biomedical Research Centre. The DIAGRAM consortium is acknowledged for sharing data. B. Jafar-Mohammadi is a Diabetes UK clinical training fellow. The authors would like to acknowledge the participants of all study cohorts for their cooperation.
###end p 47
###begin p 48
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Duality of interest</bold>
Duality of interest The authors declare that there is no duality of interest associated with this manuscript.
###end p 48
###begin p 49
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
###xml 100 105 <span type="species:ncbi:9606">human</span>
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
###end article-title 51
###begin article-title 52
###xml 31 36 <span type="species:ncbi:9606">human</span>
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
###end article-title 52
###begin article-title 53
Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities
###end article-title 53
###begin article-title 54
Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus
###end article-title 54
###begin article-title 55
Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness
###end article-title 55
###begin article-title 56
Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene
###end article-title 56
###begin article-title 57
Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study
###end article-title 57
###begin article-title 58
Limited agreement between HbA1c and glucose in the general Dutch population: The New Hoorn Study
###end article-title 58
###begin article-title 59
Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study
###end article-title 59
###begin article-title 60
A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13
###end article-title 60
###begin article-title 61
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect
###end article-title 61
###begin article-title 62
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study
###end article-title 62
###begin article-title 63
Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes
###end article-title 63
###begin article-title 64
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
###end article-title 64
###begin article-title 65
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 65
###begin article-title 66
Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes
###end article-title 66
###begin article-title 67
Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals
###end article-title 67
###begin article-title 68
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
###end article-title 68
###begin article-title 69
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 69
###begin article-title 70
Efficiency and power in genetic association studies
###end article-title 70
###begin article-title 71
Sample size requirements for association studies of gene-gene interaction
###end article-title 71
###begin article-title 72
Genetic signatures of strong recent positive selection at the lactase gene
###end article-title 72
###begin article-title 73
###xml 42 47 <span type="species:ncbi:9606">human</span>
Microsatellite variation and evolution of human lactase persistence
###end article-title 73
###begin article-title 74
###xml 34 39 <span type="species:ncbi:9606">human</span>
Positive natural selection in the human lineage
###end article-title 74
###begin article-title 75
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
###end article-title 75
###begin title 76
Abbreviations
###end title 76
###begin p 77
Denmark sample 1
###end p 77
###begin p 78
Finland sample 1
###end p 78
###begin p 79
Finland sample 2
###end p 79
###begin p 80
Genome-wide association study
###end p 80
###begin p 81
Minor allele frequency
###end p 81
###begin p 82
Normal glucose tolerance
###end p 82
###begin p 83
New Hoorn Study
###end p 83
###begin p 84
The Hoorn Study
###end p 84
###begin p 85
Second Dutch sample
###end p 85
###begin p 86
The Breda study
###end p 86
###begin p 87
ERGO Study
###end p 87
###begin p 88
Sweden sample 1
###end p 88
###begin p 89
Single nucleotide polymorphism
###end p 89
###begin p 90
UK sample 1
###end p 90
###begin p 91
UK sample 2
###end p 91
###begin p 92
Wellcome Trust Case Control Consortium
###end p 92
###begin p 93
E. Reiling and B. Jafar-Mohammadi contributed equally to this study.
###end p 93
###begin p 94
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 94
###begin p 95
The online version of this article (doi:10.1007/s00125-009-1557-7) contains supplementary material, which is available to authorised users.
###end p 95

